Abstract:
Objective: To evaluate the effectiveness of the chondroprotector ARTRA®MSM in the complex treatment of patients
with osteoarthritis. Material and methods: 33 patients were included in the study, of which 28 (73.7%) patients
with gonarthrosis in the I-II radiographic stage according to Kellgen - Lowrence, 4 (10.5%) with gonarthrosis +
synovitis and 1 (2 .6%) – with gonarthrosis + coxarthrosis. There were 27 women (81.8%), 6 men (18.2%). The average
age of patients is 58.4±5.2, the average duration of gonarthrosis is 4.1±0.5 years. Results: ARTRA®MSM, improving
metabolic processes in cartilage, is an effective drug for the treatment of osteoarthritis of the knee joints. It reduces
pain and improves joint function with complex short-term treatment with NSAIDs. It should also be noted that ARTRA
®MSM is well tolerated and safe, which did not cause serious undesirable effects in our patients. Conclusions: The
use of the drug in patients with osteoarthritis of the knee joints contributed to a significant reduction in the severity of
pain and improvement in the functional state of the joints.
